| Generation and reproductive phenotypes of mice lacking estrogen receptor β JH Krege, JB Hodgin, JF Couse, E Enmark, M Warner, JF Mahler, M Sar, ... Proceedings of the National Academy of Sciences 95 (26), 15677-15682, 1998 | 2157 | 1998 |
| Elevated blood pressures in mice lacking endothelial nitric oxide synthase EG Shesely, N Maeda, HS Kim, KM Desai, JH Krege, VE Laubach, ... Proceedings of the National Academy of Sciences 93 (23), 13176-13181, 1996 | 1122 | 1996 |
| Genetic control of blood pressure and the angiotensinogen locus. HS Kim, JH Krege, KD Kluckman, JR Hagaman, JB Hodgin, CF Best, ... Proceedings of the National Academy of Sciences 92 (7), 2735-2739, 1995 | 781 | 1995 |
| Male–female differences in fertility and blood pressure in ACE-deficient mice JH Krege, SWM John, LL Langenbach, JB Hodgin, JR Hagaman, ... Nature 375 (6527), 146-148, 1995 | 773 | 1995 |
| Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension SWM John, JH Krege, PM Oliver, JR Hagaman, JB Hodgin, SC Pang, ... Science 267 (5198), 679-681, 1995 | 772 | 1995 |
| A noninvasive computerized tail-cuff system for measuring blood pressure in mice JH Krege, JB Hodgin, JR Hagaman, O Smithies Hypertension 25 (5), 1111-1115, 1995 | 682 | 1995 |
| Effects of teriparatide versus alendronate for treating glucocorticoid‐induced osteoporosis: Thirty‐six–month results of a randomized, double‐blind, controlled trial KG Saag, JR Zanchetta, JP Devogelaer, RA Adler, R Eastell, K See, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2009 | 563 | 2009 |
| Angiotensin-converting enzyme and male fertility JR Hagaman, JS Moyer, ES Bachman, M Sibony, PL Magyar, JE Welch, ... Proceedings of the National Academy of Sciences 95 (5), 2552-2557, 1998 | 430 | 1998 |
| Estrogen inhibits the vascular injury response in estrogen receptor β-deficient female mice RH Karas, JB Hodgin, M Kwoun, JH Krege, M Aronovitz, W Mackey, ... Proceedings of the National Academy of Sciences 96 (26), 15133-15136, 1999 | 318 | 1999 |
| A randomized, double‐blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral density RR Recker, CT Benson, T Matsumoto, MA Bolognese, DA Robins, J Alam, ... Journal of Bone and Mineral Research 30 (2), 216-224, 2015 | 308 | 2015 |
| Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6‐month double‐blind placebo‐controlled trial C Deal, M Omizo, EN Schwartz, EF Eriksen, P Cantor, J Wang, EV Glass, ... Journal of Bone and Mineral Research 20 (11), 1905-1911, 2005 | 262 | 2005 |
| Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment PD Miller, EN Schwartz, P Chen, DA Misurski, JH Krege Osteoporosis international 18 (1), 59-68, 2007 | 258 | 2007 |
| Estrogen receptor α is a major mediator of 17β-estradiol’s atheroprotective effects on lesion size in Apoe–/– mice JB Hodgin, JH Krege, RL Reddick, KS Korach, O Smithies, N Maeda The Journal of clinical investigation 107 (3), 333-340, 2001 | 246 | 2001 |
| Enhanced prediction of fracture risk combining vertebral fracture status and BMD ES Siris, HK Genant, AJ Laster, P Chen, DA Misurski, JH Krege Osteoporosis international 18 (6), 761-770, 2007 | 224 | 2007 |
| PINP as a biological response marker during teriparatide treatment for osteoporosis JH Krege, NE Lane, JM Harris, PD Miller Osteoporosis International 25, 2159-2171, 2014 | 219 | 2014 |
| Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse W Huang, Y Gallois, N Bouby, P Bruneval, D Heudes, MF Belair, ... Proceedings of the National Academy of Sciences 98 (23), 13330-13334, 2001 | 205 | 2001 |
| Teriparatide for osteoporosis: importance of the full course R Lindsay, JH Krege, F Marin, L Jin, JJ Stepan Osteoporosis international 27, 2395-2410, 2016 | 203 | 2016 |
| Change in lumbar spine BMD and vertebral fracture risk reduction in teriparatide‐treated postmenopausal women with osteoporosis P Chen, PD Miller, PD Delmas, DA Misurski, JH Krege Journal of Bone and Mineral Research 21 (11), 1785-1790, 2006 | 186 | 2006 |
| Angiotensin-converting enzyme gene mutations, blood pressures, and cardiovascular homeostasis JH Krege, HS Kim, JS Moyer, JC Jennette, L Peng, SK Hiller, O Smithies Hypertension 29 (1), 150-157, 1997 | 185 | 1997 |
| National Bone Health Alliance Bone Turnover Marker Project: current practices and the need for US harmonization, standardization, and common reference ranges D Bauer, J Krege, N Lane, E Leary, C Libanati, P Miller, G Myers, ... Osteoporosis International 23, 2425-2433, 2012 | 181 | 2012 |
